Market Cap 326.50M
Revenue (ttm) 0.00
Net Income (ttm) -56.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,518,900
Avg Vol 1,706,082
Day's Range N/A - N/A
Shares Out 64.65M
Stochastic %K 22%
Beta 0.46
Analysts Strong Sell
Price Target $17.00

Company Profile

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Cor...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 500 8080
Address:
245 Main Street, Second Floor, Cambridge, United States
JuggernautRaider
JuggernautRaider Mar. 16 at 4:03 AM
Could $NVAX be a buyout target for $SNY like $IMRX is? 🧐 Speaking about Sanofi: the French 75 swept the Oscars. Much like $TNXP , from here on out it’s One Battle After Another šŸ‘Š
2 Ā· Reply
JuggernautRaider
JuggernautRaider Mar. 16 at 12:04 AM
$TNXP man I really need to create my first YouTube video breaking this down because my thumbs are falling off reexplaining this šŸ˜† I also think $NUVB $IMRX and $ALT are also grossly misunderstood. I think I’ll do 20-40 minutes weekly on 7 of my favorite biotechs. Does anyone Thoughts on a title? @BiotechBonesaw ? 1) But if you compare the net sales reported by Tonix in Q4 to the weekly Symphony summaries I’ve shared thanks to our friends at AGO, it is 1.7x ($1.4M net sales in Q4 vs the $870K or so thru the last ā€œfull weekā€ of December. If you include the week ending 1/2/26, it is 1.5x 2) Tonix just reported 4.2K total dispenses versus the 2,444 reported via Symphony thru 2/20. You can do the math yourself (this is AGP’s table taken from Bloomberg) 3) While this week’s report is delayed… March should accelerate the launch. The weather has improved in most states, payers are granting access, and millions of fibromyalgia patients are waiting to add Tonmya to their treatment arsenal šŸš€
4 Ā· Reply
JuggernautRaider
JuggernautRaider Mar. 15 at 11:24 PM
$TNXP $NVAX $IMRX $SNY well said Prop Joe! And I accept said proposition to review Novovax. I will admit that I thought of them as another ā€œme tooā€ mRNA COVID/FLU biotech. But these points are compelling and I will reexamine. Sanofi’s best deal this year IMO is their partnership with IMRX in the pancreatic cancer & other spaces. Like NUVB and SLS I wish I had bought more than a few thousand shares when they were below $2. There has been a lot of noise in the pancreatic cancer space, which is awesome as it is one of the deadliest cancers. In the meanwhile, can you please sic Brother Mouzone on some of these Tonix bears? I have blocked most of them but some still leak thru. I’ll see if I can get Omar too A biotech trader got to have a code šŸ’Š šŸ’Ŗ šŸ’„
1 Ā· Reply
MASTER_CHIEF__117
MASTER_CHIEF__117 Mar. 14 at 8:22 PM
$IMRX loaded a massive amount of shares here Friday. 6.86 gap fill otw to 18.00
1 Ā· Reply
teachutrades
teachutrades Mar. 14 at 4:48 PM
$IMRX always a dip before the rip
0 Ā· Reply
Biotech_Pharma_Investor
Biotech_Pharma_Investor Mar. 14 at 8:57 AM
$IMRX https://event.summitcast.com/view/mT9poctHDNthc6b89WqVjf/JenjdQXTpNhVHuPFyuSxqz Last part interesting. Many questionmarks on RVMD data (which RVMD has declined to disclose, despite IMRX asking for public sharing of all the data so that patients and clinicians can have an informed selection on which trial to enrol
0 Ā· Reply
JuggernautRaider
JuggernautRaider Mar. 14 at 4:42 AM
$TNXP $SLS $IMRX $ALT while we wait for more news from four of my favorite biotechs… I bet 98% of you didn’t know that Kenny Rogers sang this classic šŸ˜‚ https://www.youtube.com/watch?v=-0-7fg8oAO4
2 Ā· Reply
JuggernautRaider
JuggernautRaider Mar. 13 at 10:31 PM
$SLS it won’t take long. Bloomberg hosted a round table about the tens of billions of dollars in revenue which are coming off patent. SELLAS, $NUVB , $IMRX , $SNDX look like very compelling hematology/oncology buyout candidates ā°
0 Ā· Reply
OptimistJP
OptimistJP Mar. 13 at 5:52 PM
$IMRX who bought the 19 million shares in the last offering at $9.38? I am baffled we remain below this price which is also where Sanofi dropped $25 million. There has to be some massive bagholders.
0 Ā· Reply
Aziel_Blevins_79
Aziel_Blevins_79 Mar. 13 at 5:38 PM
0 Ā· Reply
Latest News on IMRX
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)

Dec 16, 2025, 8:00 AM EST - 3 months ago

Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)


Immuneering Corporation (IMRX) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 9:11 PM EST - 4 months ago

Immuneering Corporation (IMRX) Q3 2025 Earnings Call Transcript


Immuneering Corporation - Special Call

Sep 29, 2025, 4:37 PM EDT - 5 months ago

Immuneering Corporation - Special Call


Immuneering Appoints Dr. Thomas Schall as Chairman of the Board

Sep 16, 2025, 7:00 AM EDT - 6 months ago

Immuneering Appoints Dr. Thomas Schall as Chairman of the Board


Immuneering Announces Closing of $25 Million Private Placement

Aug 26, 2025, 4:05 PM EDT - 7 months ago

Immuneering Announces Closing of $25 Million Private Placement


Immuneering Announces $25 Million Private Placement

Aug 21, 2025, 8:00 AM EDT - 7 months ago

Immuneering Announces $25 Million Private Placement


Immuneering Corporation Announces Grant of Inducement Award

Mar 21, 2025, 4:30 PM EDT - 1 year ago

Immuneering Corporation Announces Grant of Inducement Award


Why Is Immuneering Stock Trading Higher On Tuesday?

Jan 7, 2025, 9:28 AM EST - 1 year ago

Why Is Immuneering Stock Trading Higher On Tuesday?


Immuneering Launches Pancreatic Cancer Advisory Board

Dec 19, 2024, 8:00 AM EST - 1 year ago

Immuneering Launches Pancreatic Cancer Advisory Board


Immuneering Recognizes Melanoma Awareness Month

May 6, 2024, 4:30 PM EDT - 2 years ago

Immuneering Recognizes Melanoma Awareness Month


JuggernautRaider
JuggernautRaider Mar. 16 at 4:03 AM
Could $NVAX be a buyout target for $SNY like $IMRX is? 🧐 Speaking about Sanofi: the French 75 swept the Oscars. Much like $TNXP , from here on out it’s One Battle After Another šŸ‘Š
2 Ā· Reply
JuggernautRaider
JuggernautRaider Mar. 16 at 12:04 AM
$TNXP man I really need to create my first YouTube video breaking this down because my thumbs are falling off reexplaining this šŸ˜† I also think $NUVB $IMRX and $ALT are also grossly misunderstood. I think I’ll do 20-40 minutes weekly on 7 of my favorite biotechs. Does anyone Thoughts on a title? @BiotechBonesaw ? 1) But if you compare the net sales reported by Tonix in Q4 to the weekly Symphony summaries I’ve shared thanks to our friends at AGO, it is 1.7x ($1.4M net sales in Q4 vs the $870K or so thru the last ā€œfull weekā€ of December. If you include the week ending 1/2/26, it is 1.5x 2) Tonix just reported 4.2K total dispenses versus the 2,444 reported via Symphony thru 2/20. You can do the math yourself (this is AGP’s table taken from Bloomberg) 3) While this week’s report is delayed… March should accelerate the launch. The weather has improved in most states, payers are granting access, and millions of fibromyalgia patients are waiting to add Tonmya to their treatment arsenal šŸš€
4 Ā· Reply
JuggernautRaider
JuggernautRaider Mar. 15 at 11:24 PM
$TNXP $NVAX $IMRX $SNY well said Prop Joe! And I accept said proposition to review Novovax. I will admit that I thought of them as another ā€œme tooā€ mRNA COVID/FLU biotech. But these points are compelling and I will reexamine. Sanofi’s best deal this year IMO is their partnership with IMRX in the pancreatic cancer & other spaces. Like NUVB and SLS I wish I had bought more than a few thousand shares when they were below $2. There has been a lot of noise in the pancreatic cancer space, which is awesome as it is one of the deadliest cancers. In the meanwhile, can you please sic Brother Mouzone on some of these Tonix bears? I have blocked most of them but some still leak thru. I’ll see if I can get Omar too A biotech trader got to have a code šŸ’Š šŸ’Ŗ šŸ’„
1 Ā· Reply
MASTER_CHIEF__117
MASTER_CHIEF__117 Mar. 14 at 8:22 PM
$IMRX loaded a massive amount of shares here Friday. 6.86 gap fill otw to 18.00
1 Ā· Reply
teachutrades
teachutrades Mar. 14 at 4:48 PM
$IMRX always a dip before the rip
0 Ā· Reply
Biotech_Pharma_Investor
Biotech_Pharma_Investor Mar. 14 at 8:57 AM
$IMRX https://event.summitcast.com/view/mT9poctHDNthc6b89WqVjf/JenjdQXTpNhVHuPFyuSxqz Last part interesting. Many questionmarks on RVMD data (which RVMD has declined to disclose, despite IMRX asking for public sharing of all the data so that patients and clinicians can have an informed selection on which trial to enrol
0 Ā· Reply
JuggernautRaider
JuggernautRaider Mar. 14 at 4:42 AM
$TNXP $SLS $IMRX $ALT while we wait for more news from four of my favorite biotechs… I bet 98% of you didn’t know that Kenny Rogers sang this classic šŸ˜‚ https://www.youtube.com/watch?v=-0-7fg8oAO4
2 Ā· Reply
JuggernautRaider
JuggernautRaider Mar. 13 at 10:31 PM
$SLS it won’t take long. Bloomberg hosted a round table about the tens of billions of dollars in revenue which are coming off patent. SELLAS, $NUVB , $IMRX , $SNDX look like very compelling hematology/oncology buyout candidates ā°
0 Ā· Reply
OptimistJP
OptimistJP Mar. 13 at 5:52 PM
$IMRX who bought the 19 million shares in the last offering at $9.38? I am baffled we remain below this price which is also where Sanofi dropped $25 million. There has to be some massive bagholders.
0 Ā· Reply
Aziel_Blevins_79
Aziel_Blevins_79 Mar. 13 at 5:38 PM
0 Ā· Reply
OptimistJP
OptimistJP Mar. 13 at 5:20 PM
$IMRX aggresive selling to drop it under $5, but we have a buyer collecting all shares under $5. Ironic standoff.
0 Ā· Reply
watchaddict
watchaddict Mar. 13 at 4:26 PM
$IMRX 3000 more
0 Ā· Reply
MASTER_CHIEF__117
MASTER_CHIEF__117 Mar. 13 at 4:23 PM
$IMRX yes typo…they do expire next week…they dont want to hedge and start having to buy shares today through next week. Close above 5.15ish will start it…
0 Ā· Reply
watchaddict
watchaddict Mar. 13 at 4:21 PM
$IMRX Adding
0 Ā· Reply
MASTER_CHIEF__117
MASTER_CHIEF__117 Mar. 13 at 3:57 PM
$IMRX 5.00 strikes expire today…scammy market makers are trying to pin below 5.00 so they dont have to buy shares if it closes higher. Just more manipulation on low volume…medium term this is an 18-20.00 stock…trade accordingly.
1 Ā· Reply
D541
D541 Mar. 13 at 3:53 PM
$IMRX look at $SLS
0 Ā· Reply
D541
D541 Mar. 13 at 3:47 PM
$IMRX if you look at the chart in the past two days the consolidation pattern was already disrupted, if it fails to behave like a bull flag it goes down to the first support. As we came from a few days of run up the fall looks big but no news, just chart
0 Ā· Reply
audiobookprisonstories
audiobookprisonstories Mar. 13 at 3:22 PM
$IMRX a little sketched by that volume spike down but i added some i sold at 5.70
0 Ā· Reply
Dognat
Dognat Mar. 13 at 3:18 PM
$IMRX I think a lot of people moved their stop loss up as this stock was trending up. Going to guess shorts were targeting these stop losses and were able to succeed. I can totally be wrong, but that is what makes sense to me
1 Ā· Reply
hk1914
hk1914 Mar. 13 at 3:16 PM
$IMRX Probably a large investor is dumping it? Maybe someone knows something we don't know. Anyone know some institutions that are willing to sell it?
1 Ā· Reply
longDstyle
longDstyle Mar. 13 at 3:11 PM
$IMRX something going on here …. What news is everyone seeing ?
1 Ā· Reply